ABBV ready for shortABBV seems ready for short, RSI already broken trend line.
Details are on chart.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.435 CHF
4.06 B CHF
45.73 B CHF
1.77 B
About AbbVie Inc.
Sector
CEO
Robert A. Michael
Headquarters
North Chicago
Website
Founded
2011
FIGI
BBG006M73D22
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where 4AB is featured.
Frequently Asked Questions
The current price of 4AB is 160.992 CHF — it has decreased by −0.88% in the past 24 hours. Watch ABBVIE INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange ABBVIE INC stocks are traded under the ticker 4AB.
We've gathered analysts' opinions on ABBVIE INC future price: according to them, 4AB price has a max estimate of 214.48 CHF and a min estimate of 147.45 CHF. Watch 4AB chart and read a more detailed ABBVIE INC stock forecast: see what analysts think of ABBVIE INC and suggest that you do with its stocks.
4AB stock is 1.77% volatile and has beta coefficient of 0.18. Track ABBVIE INC stock price on the chart and check out the list of the most volatile stocks — is ABBVIE INC there?
Today ABBVIE INC has the market capitalization of 284.21 B, it has increased by 3.38% over the last week.
Yes, you can track ABBVIE INC financials in yearly and quarterly reports right on TradingView.
ABBVIE INC is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
4AB earnings for the last quarter are 2.54 CHF per share, whereas the estimation was 2.47 CHF resulting in a 2.74% surprise. The estimated earnings for the next quarter are 2.69 CHF per share. See more details about ABBVIE INC earnings.
ABBVIE INC revenue for the last quarter amounts to 12.25 B CHF, despite the estimated figure of 12.10 B CHF. In the next quarter, revenue is expected to reach 13.39 B CHF.
4AB net income for the last quarter is 1.31 B CHF, while the quarter before that showed 1.22 B CHF of net income which accounts for 7.50% change. Track more ABBVIE INC financial stats to get the full picture.
Yes, 4AB dividends are paid quarterly. The last dividend per share was 1.34 CHF. As of today, Dividend Yield (TTM)% is 3.48%. Tracking ABBVIE INC dividends might help you take more informed decisions.
ABBVIE INC dividend yield was 3.87% in 2023, and payout ratio reached 220.33%. The year before the numbers were 3.53% and 86.17% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 30, 2024, the company has 50.00 K employees. See our rating of the largest employees — is ABBVIE INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ABBVIE INC EBITDA is 21.46 B CHF, and current EBITDA margin is 49.30%. See more stats in ABBVIE INC financial statements.
Like other stocks, 4AB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABBVIE INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABBVIE INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABBVIE INC stock shows the strong buy signal. See more of ABBVIE INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.